On November 14, 2022, the U.S. Supreme Court declined StarKist Company’s petition to review the Court of Appeals for the Ninth Circuit’s en banc opinion upholding certification of three.
On November 14, 2022, the U.S. Supreme Court declined StarKist Company's petition to review the Court of Appeals for the Ninth Circuit's en banc opinion upholding certification.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration.
/PRNewswire/ The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance" training has been added to ResearchAndMarkets.com s offering. This.